![Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients | Scientific Reports Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-02659-4/MediaObjects/41598_2021_2659_Fig1_HTML.png)
Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients | Scientific Reports
![Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | Science Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | Science](https://www.science.org/cms/10.1126/science.abc8378/asset/5a4937bb-5887-4867-ac18-835684e1921e/assets/graphic/371_abc8378_fa.jpeg)
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | Science
![Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet](https://www.thelancet.com/cms/attachment/10908718-d982-4518-bb9d-f5761b50b8fe/gr1_lrg.jpg)
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet
![Vaccines | Free Full-Text | Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose Vaccines | Free Full-Text | Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose](https://www.mdpi.com/vaccines/vaccines-10-00153/article_deploy/html/images/vaccines-10-00153-g001.png)
Vaccines | Free Full-Text | Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose
![Anti-SARS-CoV-2 IgM/IgG antibodies detection using a patch sensor containing porous microneedles and a paper-based immunoassay | Scientific Reports Anti-SARS-CoV-2 IgM/IgG antibodies detection using a patch sensor containing porous microneedles and a paper-based immunoassay | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-14725-6/MediaObjects/41598_2022_14725_Fig1_HTML.png)
Anti-SARS-CoV-2 IgM/IgG antibodies detection using a patch sensor containing porous microneedles and a paper-based immunoassay | Scientific Reports
![Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine](https://pub.mdpi-res.com/diagnostics/diagnostics-11-01135/article_deploy/html/images/diagnostics-11-01135-g001.png?1624443295)
Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
![Neurological disorders-associated anti-glycosphingolipid IgG-antibodies display differentially restricted IgG subclass distribution | Scientific Reports Neurological disorders-associated anti-glycosphingolipid IgG-antibodies display differentially restricted IgG subclass distribution | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-70063-5/MediaObjects/41598_2020_70063_Fig1_HTML.png)